Work

A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma

Year: 2001

Type: article

Study designs: Randomized Controlled Trial, Clinical Trial

Source: Journal of the American Academy of Dermatology

DOI: 10.1067/mjd.2001.113478

Authors: Madeleine Duvic, Elise A. Olsen, George A. Omura, John C. Maize, Eric C. Vonderheid, Craig A. Elmets, Jerome L. Shupack, Marie-France Demierre, Timothy M. Kuzel, Deborah Y. Sanders

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Cutaneous lymphoproliferative disorders research

Subfield: Dermatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2105872376

FWCI: 4.205

Cites: 16

Cited by: 56

Related to: 10